North County Times - “International Stem Cell CEO Krstich Dies” By: BRADLEY J. FIKES - Staff Writer
OCEANSIDE ---- Jeff Krstich, chief executive of International Stem Cell Corp., died Jan. 20, the company announced Tuesday.
Krstich, 60, died of "an apparent heart attack", the company said in a press release. Kenneth C. Aldrich, chairman, has replaced Krstich as chief executive and will retain the chairman title.
The Oceanside-based company (ticker ISCO, which trades over the counter) is developing therapies from stem cells derived from unfertilized, or parthogenic, human egg cells.
"We are all shocked that Jeff would be taken at such a young age, but we are determined to use this tragic event as motivation to vigorously pursue stem-cell based therapeutic remedies that would help to fulfill Mr. Krstich's dream," Aldrich stated.
To read the article in full, please visit the Source Link Below
Source: http://www.nctimes.com/articles/2008/01/22/business/news/6_31_761_22_08.txt
Signs on San Diego - “CEO inspired others at his company, in personal life” By Terri Somers UNION-TRIBUNE STAFF WRITER
January 23, 2008
Whether he was meeting with his employees at International Stem Cells Inc. or coaching diminutive 5-year-olds in flag football, Jeff Krstich made people feel good about themselves and their contribution to the team effort, people who knew him say.
Or, as one International Stem Cell consultant said, “He always made me feel like I was the brightest penny in the room.”
Krstich, a former Navy test pilot who had been CEO at the Oceanside-based company since 2006, died Sunday of a heart attack. He was 60.
Friends, relatives and colleagues expressed shock yesterday that the robust and fit former captain of the U.S. Naval Academy football team, who had played lacrosse Saturday, is now gone.
“He was one of, if not the best, person I ever worked with in my entire career because he had vision and knew where we were going and made you so happy to be there,” said Jeffrey Janus, president of International Stem Cells.
To read the article in full, please visit the Source Link BelowSource: http://www.signonsandiego.com/news/business/biotech/20080123-9999-1b23iscc.htmll
No comments:
Post a Comment